Gender differences in acute coronary syndromes: focus on the women with ACS without an obstructing culprit lesion

References

• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603.
   PubMed Web of Science ®Google Scholar
• Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47:S21–9.
   PubMed Web of Science ®Google Scholar
• Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133:916–947.
   PubMed Web of Science ®Google Scholar
• Grundtvig M, Hagen TP, German M, et al. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil. 2009;16:174–179.
   PubMedGoogle Scholar
• Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316:1043–1047.
   PubMed Web of Science ®Google Scholar
• Prescott E, Osler M, Andersen PK, et al. Mortality in women and men in relation to smoking. Int J Epidemiol. 1998;27:27–32.
   PubMed Web of Science ®Google Scholar
• Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73–78.
   PubMed Web of Science ®Google Scholar
• Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010;18:598–602.
   PubMed Web of Science ®Google Scholar
• Canoy D, Beral V, Balkwill A, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation. 2015;131:237–244.
   PubMed Web of Science ®Google Scholar
• Lakshman R, Forouhi NG, Sharp SJ, et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab. 2009;94:4953–4960.
   PubMed Web of Science ®Google Scholar
• Mueller NT, Odegaard AO, Gross MD, et al. Age at menarche and cardiovascular disease mortality in Singaporean Chinese women: the Singapore Chinese Health Study. Ann Epidemiol. 2012;22:717–722.
   PubMed Web of Science ®Google Scholar
• Won JC, Hong JW, Noh JH, et al. Association between age at menarche and risk factors for cardiovascular diseases in Korean women: the 2010 to 2013 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore). 2016;95:e3580.
   PubMed Web of Science ®Google Scholar
• Charalampopoulos D, McLoughlin A, Elks CE, et al. Age at menarche and risks of all-cause and cardiovascular death: a systematic review and meta-analysis. Am J Epidemiol. 2014;180:29–40.
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Jama. 1998;280:605–613.
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:49–57.
   PubMed Web of Science ®Google Scholar
• Yang D, Li J, Yuan Z, et al. Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One. 2013;8:e62329.
   PubMedGoogle Scholar
• Gabriel SR, Carmona L, Roque M, et al. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2005;CD002229.
   PubMed Web of Science ®Google Scholar
• Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med. 2002;137:273–284.
   PubMed Web of Science ®Google Scholar
• Roehm E. Hormone therapy use and outcomes in the Women’s Health Initiative trials. JAMA. 2014;311:417.
   PubMed Web of Science ®Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310:1353–1368.
   PubMed Web of Science ®Google Scholar
• Appiah D, Schreiner PJ, Bower JK, et al. Is surgical menopause associated with future levels of cardiovascular risk factor independent of antecedent levels? The CARDIA study. Am J Epidemiol. 2015;182:991–999.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
   PubMed Web of Science ®Google Scholar
• Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1–19.
   PubMed Web of Science ®Google Scholar
• Murphy MS, Smith GN. Pre-eclampsia and cardiovascular disease risk assessment in women. Am J Perinatol. 2016;33:723–731.
   PubMed Web of Science ®Google Scholar
• Rylander R. Pre-eclampsia during pregnancy and cardiovascular disease later in life: the case for a risk group. Arch Gynecol Obstet. 2015;292:519–521.
   PubMed Web of Science ®Google Scholar
• Udenze IC. Association of pre-eclampsia with metabolic syndrome and increased risk of cardiovascular disease in women: a systemic review. Niger J Clin Pract. 2016;19:431–435.
   PubMed Web of Science ®Google Scholar
• Tanz LJ, Stuart JJ, Williams PL, et al. Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women. Circulation. 2017;135:578–589.
   PubMed Web of Science ®Google Scholar
• Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009;53:221–231.
   PubMed Web of Science ®Google Scholar
• Pizzi C, Xhyheri B, Costa GM, et al. Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: a meta-analysis. J Am Heart Assoc. 2016;5:e004185.
   PubMed Web of Science ®Google Scholar
• Min JK, Dunning A, Lin FY, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter CONFIRM (Coronary CT angiography evaluation for clinical outcomes: an international multicenter registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58:849–860.
   PubMed Web of Science ®Google Scholar
• Bugiardini R. Women, ‘non-specific’ chest pain, and normal or near-normal coronary angiograms are not synonymous with favourable outcome. Eur Heart J. 2006;27:1387–1389.
   PubMed Web of Science ®Google Scholar
• Puddu PE, Iannetta L, Schiariti M. Age- and gender-normalized coronary incidence and mortality risks in primary and secondary prevention. Cardiol Res. 2012;3:193–204.
   PubMedGoogle Scholar
• Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297:611–619.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Paynter NP, Rifai N, et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation. 2008;118: 2243–2251. 4p following 51.
   PubMed Web of Science ®Google Scholar
• Cook NR, Paynter NP, Eaton CB, et al. Comparison of the Framingham and Reynolds risk scores for global cardiovascular risk prediction in the multiethnic women’s health initiative. Circulation. 2012;125(1748–56):S1–11.
   Google Scholar
• Hilbers FS, Boekel NB, van den Broek AJ, et al. Genetic variants in TGFbeta-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer. Radiother Oncol. 2012;102:115–121.
   PubMed Web of Science ®Google Scholar
• Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost. 1997;78:656–660.
   PubMed Web of Science ®Google Scholar
• Salmenniemi U, Ruotsalainen E, Pihlajamaki J, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation. 2004;110:3842–3848.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006;3:35–42.
   PubMedGoogle Scholar
• Xing D, Nozell S, Chen YF, et al. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol. 2009;29:289–295.
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291:1701–1712.
   PubMed Web of Science ®Google Scholar
• Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Arch Intern Med. 2006;166:357–365.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–1477.
   PubMed Web of Science ®Google Scholar
• Miller AP, Chen YF, Xing D, et al. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension. 2003;42:657–663.
   PubMedGoogle Scholar
• Miller VM, Clarkson TB, Harman SM, et al. Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol. 1985;2005(99):381–383.
   Google Scholar
• Chen SJ, Li H, Durand J, et al. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577–584.
   PubMed Web of Science ®Google Scholar
• Levine RL, Chen SJ, Durand J, et al. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation. 1996;94:2221–2227.
   PubMed Web of Science ®Google Scholar
• Oparil S, Chen SJ, Chen YF, et al. Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries. Cardiovasc Res. 1999;44:608–614.
   PubMed Web of Science ®Google Scholar
• Oparil S, Levine RL, Chen SJ, et al. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation. 1997;95:1301–1307.
   PubMed Web of Science ®Google Scholar
• Tolbert T, Thompson JA, Bouchard P, et al. Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model. Circulation. 2001;104:2740–2745.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995;214:847–855.
   PubMed Web of Science ®Google Scholar
• Kim KH, Young BD, Bender JR. Endothelial estrogen receptor isoforms and cardiovascular disease. Mol Cell Endocrinol. 2014;389:65–70.
   PubMed Web of Science ®Google Scholar
• Bottner M, Thelen P, Jarry H. Estrogen receptor beta: tissue distribution and the still largely enigmatic physiological function. J Steroid Biochem Mol Biol. 2014;139:245–251.
   PubMed Web of Science ®Google Scholar
• Xing D, Feng W, Miller AP, et al. Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation. Am J Physiol Heart Circ Physiol. 2007;292:H2607–12.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132:344–362.
   PubMed Web of Science ®Google Scholar
• Kalaitzidis D, Gilmore TD. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab. 2005;16:46–52.
   PubMed Web of Science ®Google Scholar
• Lichtman JH, Leifheit-Limson EC, Watanabe E, et al. Symptom recognition and healthcare experiences of young women with acute myocardial infarction. Circ Cardiovasc Quality Outcomes. 2015;8:S31–8.
   PubMed Web of Science ®Google Scholar
• Diercks DB, Owen KP, Kontos MC, et al. Gender differences in time to presentation for myocardial infarction before and after a national women’s cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG). Am Heart J. 2010;160:80–7 e3.
   PubMed Web of Science ®Google Scholar
• Titterington JS, Hung OY, Wenger NK. Microvascular angina: an update on diagnosis and treatment. Future Cardiol. 2015;11:229–242.
   PubMed Web of Science ®Google Scholar
• Jiang W, Samad Z, Boyle S, et al. Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. J Am Coll Cardiol. 2013;61:714–722.
   PubMed Web of Science ®Google Scholar
• Narula J, Nakano M, Virmani R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013;61:1041–1051.
   PubMed Web of Science ®Google Scholar
• Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933–939.
   PubMed Web of Science ®Google Scholar
• Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226–235.
   PubMed Web of Science ®Google Scholar
• Lansky AJ, Ng VG, Maehara A, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovascular Imaging. 2012;5:S62–72.
   PubMed Web of Science ®Google Scholar
• Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124:1414–1425.
   PubMed Web of Science ®Google Scholar
• Manfrini O, Mont E, Leone O, et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol. 2006;98:156–159.
   PubMed Web of Science ®Google Scholar
• Guagliumi G, Capodanno D, Saia F, et al. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv. 2014;7:958–968.
   PubMedGoogle Scholar
• Alfonso F, Paulo M, Lennie V, et al. Spontaneous coronary artery dissection: long-term follow-up of a large series of patients prospectively managed with a “conservative” therapeutic strategy. JACC Cardiovasc Interv. 2012;5:1062–1070.
   PubMed Web of Science ®Google Scholar
• Alfonso F, Paulo M, Gonzalo N, et al. Diagnosis of spontaneous coronary artery dissection by optical coherence tomography. J Am Coll Cardiol. 2012;59:1073–1079.
   PubMed Web of Science ®Google Scholar
• Mortensen KH, Thuesen L, Kristensen IB, et al. Spontaneous coronary artery dissection: a Western Denmark Heart Registry study. Catheterization Cardiovascular Intervention. 2009;74:710–717.
   PubMed Web of Science ®Google Scholar
• Ghadri JR, Cammann VL, Templin C. The international Takotsubo registry: rationale, design, objectives, and first results. Heart Fail Clin. 2016;12:597–603.
   PubMed Web of Science ®Google Scholar
• Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of Takotsubo (Stress) cardiomyopathy. N Engl J Med. 2015;373:929–938.
   PubMed Web of Science ®Google Scholar
• Naegele M, Flammer AJ, Enseleit F, et al. Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome. Int J Cardiol. 2016;224:226–230.
   PubMed Web of Science ®Google Scholar
• Luscher TF, Templin C. Is Takotsubo syndrome a microvascular acute coronary syndrome? Towards of a new definition. European Heart Journal. 2016;37:2816–2820.
   PubMed Web of Science ®Google Scholar
• Ghadri JR, Sarcon A, Diekmann J, et al. Happy heart syndrome: role of positive emotional stress in Takotsubo syndrome. European Heart Journal. 2016;37:2823–2829.
   PubMed Web of Science ®Google Scholar
• Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med. 1998;105:32S–9S.
   PubMedGoogle Scholar
• Eshtehardi P, Luke J, McDaniel MC, et al. Intravascular imaging tools in the cardiac catheterization laboratory: comprehensive assessment of anatomy and physiology. J Cardiovasc Transl Res. 2011;4:393–403.
   PubMed Web of Science ®Google Scholar
• Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–658.
   PubMed Web of Science ®Google Scholar
• Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126:753–767.
   PubMed Web of Science ®Google Scholar
• Kern MJ, Lerman A, Bech JW, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on diagnostic and interventional cardiac catheterization, council on clinical cardiology. Circulation. 2006;114:1321–1341.
   PubMed Web of Science ®Google Scholar
• Francesco Radico VC, Zimarino M, Raffaele DC. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv. 2014;7:453–463.
   Google Scholar